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Abstract
Background—A simple and effective Heart Failure (HF) risk score would facilitate the primary
prevention and early diagnosis of HF in general practice. We examined the external validity of
existing HF risk scores, optimized a 10-year HF risk function, and examined the incremental value
of several biomarkers, including NT-proBNP.
Methods and Results—During 15.5 years (210,102 person-years of follow-up), 1487 HF
events were recorded among 13,555 members of the bi-ethnic Atherosclerosis Risk in
Communities (ARIC) Study cohort. The area under curve (AUC) from the Framingham-published,
Framingham-recalibrated, Health ABC HF recalibrated, and ARIC risk scores were 0.610, 0.762,
0.783, and 0.797, respectively. Upon addition of NT-pro-BNP, the optimism corrected AUC of the
ARIC HF risk score increased from 0.773 (95% CI: 0.753 – 0.787) to 0.805 (95% CI: 0.792 –
0.820). Inclusion of NT-proBNP improved the overall classification of re-calibrated Framingham,
re-calibrated Health ABC, and ARIC risk scores by 18%, 12%, and 13%, respectively. In contrast,
Cystatin C or hs-CRP did not add towards incremental risk prediction.
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Conclusions—The ARIC HF risk score is more parsimonious yet performs slightly better than
the extant risk scores in predicting 10-year risk of incident HF. The inclusion of NT-proBNP
markedly improves HF risk prediction. A simplified risk score restricted to a patient’s age, race,
gender, and NT-proBNP performs comparably to the full score (AUC = 0.745), and is suitable for
automated reporting from laboratory panels and electronic medical records.
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Each year about 500,000 individuals are diagnosed with heart failure (HF) for the first time
in the U.S.1 In the setting of advances in clinical management, the incidence as well as the
prevalence of HF have increased2. While progress in the therapy of HF appears to be
associated with improved survival, greater efforts are needed towards early detection of
ventricular dysfunction and the prevention of symptomatic heart failure3.
Most HF patients present for the first time and are managed by general practitioners (GPs)4.
However, both a poor appreciation of the importance of early diagnosis and treatment of LV
dysfunction5, and poor confidence in establishing HF diagnosis6 may be important barriers
to HF management. Appropriate risk stratification tools7 can alert the clinician to patients at
high risk of development of HF long-term, allowing for their risk factors to be aggressively
managed while still primarily under primary care. A risk prediction score that is
parsimonious, based on information easily available to the GP, and effective is required to
implement the ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure
in Adults (2009 update)8.
We examined the external validity of the extant HF risk scores, i.e., the Framingham Heart
Study 9 and Health ABC10, 11 scores in the large, bi-racial cohort of middle aged participants
sampled from four US communities by the Atherosclerosis Risk in Communities (ARIC)
Study. We also derived a parsimonious HF risk function focused on primary care settings,
called here the ‘ARIC HF risk score,’ and gauged its performance relative to the
Framingham and Health ABC functions in predicting the 10-year risk of HF. Given the
increasing use of biomarkers in clinical settings, we also examined the incremental value of
few biomarkers, including N-terminal pro-B-type natriuretic peptide (NT-proBNP), for the
long term risk prediction of HF.
Methods
Study population
The ARIC Study enrolled 15,792 men and women ages 45–64 years sampled from four U.S.
communities12. Baseline examinations of the cohort were conducted from 1987 to 1989 to
collect standardized information on socioeconomic indicators, medical history, family
history, cardiovascular risk factors, serum chemistries, electrocardiograms (ECGs), and
medication use. Three re-examinations, annual telephone interviews and active surveillance
of hospitalizations and death followed the baseline visit. The last complete cohort visit was
done in 1996–98.
Analysis involved use of covariates at two different index visits i.e., at the baseline
examination (1987–89) and at visit 4 (1996–98). For analyses using baseline data, those with
prevalent HF (n=775) or missing (n=325) data on HF13; missing information on any of the
predictors shown in Table 1 (n=1502); or race other than black or white (n= 48) were
excluded, thus leaving a cohort of 13,555 observations for analysis. After derivation of the
ARIC HF model, we compared the beta estimates and discrimination statistics with those
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from a dataset that excluded observations with missing information only for variables
included in the final model (n = 279); all estimates were found to be quite similar.
Several biomarkers included in these analyses were assayed from stored specimens from this
last visit (visit 4). From the 11,656 cohort members examined at the ARIC field centers
during visit 4, those with prevalent HF at baseline visit (n= 469) and those with incident HF
between baseline visit and visit 4 (n = 227) were excluded; those not self-identified as black
or white (n=31), and those missing any important covariate (n = 187) or NT-proBNP
(n=327) or NT-pro-BNP values ≥ 6025 pg/mL (n=6), were excluded, thus leaving a sample
of 10,106 for the analyses using visit 4 as index visit.
Predictors of heart failure
Prevalent coronary heart disease (CHD) was ascertained from medical history as well as the
adjudicated baseline ECG. Following 5 minutes of rest and while seated, blood pressure was
measured three times using a random-zero sphygmomanometer, and an average of the last 2
readings was taken. Serum glucose was measured using the hexokinase method. Diabetes
was defined by the presence of any serum glucose level >= 200 mg/dl, an 8-hour fasting
glucose level >=126 mg/dl, a self-reported history of diabetes, or the current use of
medications for diabetes. Cigarette smoking status was defined as self reported current
smoking. The self reported average number of cigarettes/day and numbers of years of
smoking were multiplied to derive cigarette-years of smoking, and this number was divided
by 20 to get pack-years of smoking. COPD was defined as a self report of physician
diagnosis of either emphysema or chronic bronchitis (or a chronic lung disease when using
visit 4 as baseline). Body mass index was defined as the ratio of measured weight (in
kilograms) and measured height2 (in meters2). Race and was identified at baseline as White,
Black, American Indian or Alaskan Indian, or Asian or Pacific Islander.
An auscultatory finding of either a diastolic murmur or a systolic murmur of grade 4 or
above by a trained physician assistant was considered as positive for presence of a valvular
heart disease (VHD). A supine 12-lead ECG at rest was obtained using the MAC PC10
personal cardiogram (Marquette Electronics, Milwaukee, Wisconsin). Processing,
monitoring, and quality control of the ECG data have been described elsewhere 14. The
presence of left ventricular hypertrophy was defined as a Cornell voltage >28 mm in men or
>22 mm in women when using a 12 lead resting ECG. QRS duration (derived from 10
second resting ECG) of >120 ms as commonly used in clinical settings was used to define
bundle branch block (BBB) was used as a binary variable.
In addition to N-terminal pro - B type natriuretic peptide (NT – pro BNP), two biomarkers
putatively predictive of HF were considered. Using stored samples from visit 4 (1996–98),
high-sensitive C-reactive protein (hs-CRP) using the immunoturbidimetric assay15, cystatin
C employing particle-enhanced immunonephelometry16, and NT-proBNP using the Elecsys
proBNP II immunoassay17 were assayed.
Characterization of Heart Failure
Incident HF was defined as the first HF hospitalization or presence of HF code on death
certificate since baseline visit through 2007. These events were identified from hospital
discharge records and death certificates that showed a HF code in any position. International
Classification of Diseases Code, Ninth Revision (ICD-9) code 428.x, and deaths with
ICD-9/10 codes of either 428.x or I50 were considered as HF. The % agreement between HF
events adjudicated by a standardized physician panel and ICD-9 code 428.x at any position
was 73%, similar to that with the Framingham HF criteria (70%)18.
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The following analyses were done using SAS version 9.2 statistical software, SAS Institute,
Cary, NC. Means (standard deviations) and proportions of characteristics at baseline were
estimated by incident HF status. Cox proportional hazard models were used to estimate age,
race, and gender independent hazard ratios for presence vs. absence (categorical variables),
or per SD increment (for continuous variables). Those without incident HF were censored at
death or at the end of study follow up. Model performance measures such as area under the
ROC curve (AUC) was estimated for discrimination, and Gronnesby-Borgan (GB)
statistics19 for model fit. Also, Log likelihood ratio chi-square statistics were estimated by
subtracting −2 log likelihood of model containing age, race, gender, and each variable from
−2 log likelihood of a model with age, race, and gender only. Since net reclassification
improvement (NRI) may be more meaningful for clinical decision making than the AUC20,
it was estimated for cut-offs for 10-year risk (<5%, 5 to <10%, 10 to <20%, and 20% or
more)20, 21. All the variables presented in Table 1 with the exception of gender and race
were retained when using likelihood ratio chi-square test with backward elimination exit
criteria p value of 0.1. AUC, NRI, and IDI were estimated by methods which allow these to
vary by time and which account for censoring 22. The variables considered in optimizing an
HF risk score in ARIC are shown in Appendix Table 1. To test the external validity of the
extant risk functions in the ARIC study population, we estimated each participant’s risk
score by multiplying the published regression coefficients from the extant risk functions 9, 11
by the respective measurements for the ARIC cohort members. A Cox regression model was
then fit with the risk function as the sole independent variable and performance statistics
were estimated. Model fits for 5 and 10 years of follow-up yielded estimates that were quite
similar. For the estimation of performance statistics of extant scores, we used both published
regression coefficients9–11, and regression coefficients derived within the ARIC cohort
using the variables in the respective risk scores.
To derive the ARIC risk function we computed AUC for multiple models starting with
variables that contributed most to AUC independently, while considering their easy
availability to the primary care practitioners and measurement quality characteristics in
practice settings.
To test the incremental value of NT-proBNP to the performance of the ARIC study risk
score we considered NT-proBNP and its log transformation after exclusion of 6 observations
with NT-pro-BNP values ≥ 6025 pg/mL, which upon examination were considered
influential outliers. We evaluated models linear in NT-proBNP, polynomial in NT-proBNP,
piecewise linear in NT-proBNP, categorical with 6 categories (percentiles 20, 40, 60, 80, 90)
and categorical with 7 categories (20, 40, 60, 80, 90, and 95), linear in log (NT-proBNP),
polynomial in log (NT-proBNP), and piecewise linear in log (NT-proBNP). The
comparative fit of these models is summarized in Appendix Figures 1a and 1b, and the
comparative index of discrimination in Appendix Table 2. Given its fair discrimination
performance, model fit, and simplicity of use, log (NT-proBNP) was chosen for these
analyses, though it is not the best fitting transformation at the lower tail of the distribution.
To obtain stable estimates for AUC corrected for optimism, due to fitting the risk score in
the sample from which it was derived, 1000 bootstrap samples were processed to achieve
stable estimates with lower bias than split-sample and cross-validation23. The average
optimism i.e., (measurebootstrap samples – measureoriginal dataset) was subtracted from the
original performance measure.
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Derivations of the ARIC HF risk score
Based on an average of 15.5 years of follow-up since baseline, 1487 (11%) incident HF
events were observed in the 13,555 cohort members. The characteristics of study
participants at baseline by incident HF status, as well as age, race, and gender adjusted
hazard ratios, AUC, and GB statistics of models for each additional variable are presented in
Table 1. Briefly, NT-proBNP, diabetes, blood pressure-lowering medication use and BMI
each contributed more than 0.03 to the AUC of a model that included age, race, and gender
only (AUC = 0.673).
Next we compared the AUC of several multivariable models to predict 10-year risk of HF,
detailed in Appendix Table 1. The main criteria in the selection of candidate variables and
model building were a) easy availability of the measurements to primary care physicians, b)
measurement reliability, and c) parsimony relative to the degree of improvement in the
AUC. Based on the above, the optimal model in the prediction of 10-year HF risk in the
ARIC population included age, race, gender, prevalent CHD, systolic blood pressure, use of
blood pressure-lowering medication, diabetes, smoking status, heart rate, and body mass
index. After correction for optimism, the AUC achieved by this model was 0.7937 (95% CI
= 0.7932, 0.7942). Appendix Figure 2 displays the predicted and observed events in the
ARIC cohort from the ARIC risk function, by deciles of risk prediction score. While less
than 5% of the cohort members below the 50th percentile had an HF event in 10 years, more
than 30% of cohort members in the highest decile had an HF event. The ratio of predicted
probability of those in the highest decile as compared to those in the lowest decile was 24.8,
and the absolute 10 years risk difference was 31.2%.
The variables included in the HF risk score to predict 10 years of HF risk and their
regression coefficients (log of hazard ratio of heart failure) are shown in Table 2 for all
participants and by race and gender. Similarly, we have included yearly estimates from the
baseline survival function in Supplemental Table 3. Modest variability in the magnitude and
direction of associations can be seen by race and gender but there is limited statistical power
to differentiate these associations in subsets of the cohort. The plots of 10-year risk of HF
vs. percentile of risk shown in Figure 1 depict the overall goodness of fit achieved. We
explored several fits for NT-proBNP on HF as an outcome. Although the fit was improved
in piecewise models, the discrimination achieved was similar. Analysis repeating the
piecewise linear fit (in log (proBNP)) after changing the lowest and highest knots to 10/90
percentiles of cases instead of 5/95 showed negligible differences in performance.
External validation of extant risk scores and comparison with the ARIC risk score model
Table 3 presents the AUC and model fit statistics for the ARIC, the Framingham and the
Health ABC risk functions based on models fit to predict the 10-year risk of HF. The AUC
for the Framingham and the Health ABC risk scores were estimated using the published beta
estimates from the respective cohorts, as well as with beta coefficients estimated in the
ARIC cohort using the variables of the respective risk scores, as described in the methods
section. The AUC from the ARIC HF risk function was highest at 0.7966; the AUCs
estimated in the ARIC cohort using variables from the Framingham HF risk score (0.7618),
and using the variables in the Health ABC risk score (0.7835) were lower. The AUCs
estimated using published coefficients from the Framingham and the Health ABC HF risk
scores were 0.6139, and 0.7848, respectively. Reclassification using the ARIC HF risk score
improved the overall classification of the individuals classified by the Framingham HF risk
score: the net improvement score subtracting off the percentage of worsening classification
from the percentage of improving classification was 13.5%. The gains in reclassification
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using the ARIC risk score relative to that of the Health ABC risk score (which includes
additional variables) were modest (NRI=3%). The overall goodness of fit by decile of risk
score was good for the three risk functions, although the large number of events led to a
sensitivity of the GB test.
Incremental value of biomarkers
With visit 4 as baseline, the average follow-up was 9.6 years, yielding 870 incident HF
events in the 10,109 followed through 2007 (8.6%).
High sensitivity C-reactive protein (hs-CRP) did not contribute appreciably to the prediction
of HF beyond that of a model with age, race, and gender only (AUC = 0.668 vs. 0.663), nor
relative to the ARIC HF risk model (AUC = 0.772 without vs. 0.775 with hs-CRP) which
yielded an NRI of 0.4%. Similarly, cystatin C did not improve the ability to predict the 10
year risk of HF compared to model with age, race, and gender only (AUC = 0.668 vs.
0.672), nor to the ARIC HF risk model (0.772 without vs. 0.779 cystatin C; NRI of 3.2%).
These two biomarkers were not considered further.
Of all the variables shown in Table 1, NT-proBNP had the largest contribution to the AUC
once added to a model based on the 1996–98 exam data containing age, gender, and race
(data not shown). The AUC of the model that included age, race, gender, and NT-proBNP
was 0.745. NT-proBNP was modeled using several distribution-based approaches to the
treatment of NT-proBNP, as shown in Appendix Figures 1a and 1b; the resulting indices of
discrimination and of fit of these models can be seen in Appendix Table 2. For ease of
replication and use in practice, the log transformation of NT-proBNP was selected for
further analyses.
The AUC of the ARIC HF risk score model (basic) compared to this model with the addition
of NT-proBNP is shown in Appendix Figure 3. The AUC of the ARIC HF risk score model
at visit 4 after addition of log(NT-proBNP) was 0.805 (95% CI: 0.792 – 0.820) as compared
to 0.773 (95% CI: 0.753 – 0.787) of the risk model without this biomarker. The increment in
the AUC is 0.032 is statistically significantly different from 0 (P<0.05). . The NRI following
the addition of NT-proBNP was 13% (95% CI: 10.2, 19.9%) as shown in Table 4, with an
integrated discrimination index (IDI) of 0.057 (95% CI: 0.043, 0.076). Inclusion of NT-
proBNP in the Framingham HF risk score derived within the ARIC cohort achieved an AUC
value of 0.792 (base model = 0.760), a NRI of 18% and IDI of 0.044. The corresponding
AUC for the Health ABC risk score after addition of NT-proBNP was 0.799 (base model =
0.777), a NRI of 12% and an IDI of 0.036.
Considerable overlap in the AUC of models with NT-proBNP was observed when males
(AUC 0.812; 0.795 – 0.833) were compared to females (0.799; 0.782 – 0.821). However, the
NRI based on NT-proBNP was slightly higher in women = 17.9% (8.9, 23.3) compared to
men 14.4% (8.2, 22.0).
Discussion
We optimized a parsimonious linear combination of variables to estimate the 10-year risk of
incident HF in a population sample of men and women aged 45–64 years, based on
information readily available in primary care settings. Compared to the extant HF risk
scores, this ARIC HF risk function includes fewer variables and performs better than the
Framingham abbreviated model and comparably to the Health ABC HF prediction model in
terms of discrimination, using both traditional (AUC) and newer measures (NRI). Overall,
the goodness of fit across deciles of risk was satisfactory. Addition of NT-pro BNP
increased the AUC of the ARIC HF model by 0.03. Considering that the AUC of the ARIC
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HF model was already high at 0.77 addition of this biomarker achieves a notable
improvement relative to what is commonly seen in the literature after addition of multiple
predictor variables.
Heart failure is a heterogeneous syndrome and often the culmination of prolonged and
complex pathological processes 24. In this respect, the robust discrimination ability for HF is
remarkable, and comparable if not higher than the AUC statistics generally observed in
CHD risk prediction, especially among women 25.
The Framingham HF risk score did not perform well in this sample, even when restricted to
characteristics similar to the original derivation cohort (data not shown); in contrast, the
discrimination achieved by the Health ABC risk score was good. The derivation cohorts for
these risk scores are different, i.e., unselected middle aged participants in ARIC, a selected
cohort of healthy elderly in the Health ABC, and a cohort with selective comorbidities in the
Framingham HF risk score. The Health ABC risk score was validated in the CHS cohort26;
although the Health ABC cohort includes African Americans, race was not included as a
variable in the reported risk score.
The addition of NT-proBNP to risk models markedly improved 10-year HF risk prediction.
Remarkably, the AUC of a model restricted to age, gender, race, and NT-proBNP is
comparable to the AUC statistics achieved for most multivariable risk prediction equations.
These results open the prospect of simple, automated estimates of the 10-year risk of HF to
accompany the NT-proBNP values reported by clinical laboratories, similar to the current
practice of automated reporting of an estimated glomerular filtration rate with measurements
of serum creatinine.
While age and sex are almost invariably recorded and thus available, race may be missing in
EMR and administrative claims data. We therefore estimated the impact of race on the
performance of the full and the “simplified” ARIC models. In the ‘simple’ model (based
only on age, sex, log NT-proBNP) the AUC was 0.7369, compared to an AUC of 0.7412 on
addition of race (an increment of 0.0043). The risk in the highest decile - lowest decile for
the former model was (28.5% – 1.5% = 27%), compared to (29.1% – 1.5% = 27.6%).
Similarly, for a model with age, gender, diabetes, hypertension (clinically diagnosed), and
current smoking the AUC was 0.7428, compared to the AUC of the same model following
the addition of race 0.7437 (an increment of 0.0009).
Lastly, for the optimized ARIC risk score model with age, gender, diabetes, hypertension,
systolic blood pressure, heart rate, body mass index, current and former smoking the AUC
was 0.7734, compared to the AUC of 0.7733 for same model with addition of race
(essentially unchanged).
Other measurements commonly available in clinical settings, such as ECG-defined left
ventricular hypertrophy and the QRS interval, and serum markers such as creatinine,
albumin, and HDL cholesterol, did not contribute importantly to the AUC for HF prediction,
possibly reflecting saturation of the models, intermediate variable effects, modest
collinearity with variables already in the model, or a low prevalence in this population-based
cohort. Other proxy measures of fat mass such as waist circumference or waist to hip ratio
may provide similar predictive value as BMI. These were not considered due to the
widespread use of BMI in clinical settings and the higher measurement error associated with
the other measures.
Convenient access to the predictor variables in the risk score, ease of use, parsimony in the
number of predictor variables and the ability to modify the factors that adversely influence a
patient’s risk also seem influential for acceptability in clinical practice. A risk score with
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these characteristics that can penetrate clinical practice can serve to identify patients at
intermediate or high levels of predicted risk of HF who may benefit from education,
aggressive risk factor management, regularly scheduled visits, and timely use of diagnostic
testing or referral to a cardiologist, if felt necessary by the general practitioner. Current
trends toward an increasing use of electronic medical records and availability of simple
computational tools to practitioners may increase the penetrance and impact of risk
estimation tools and research in this area will be needed. Prevention of the progression of
Stage A HF to stages B or C, as highlighted in the guidelines recently released by several
professional organizations8, 27, will require an ability for simple and effective HF risk
stratification in general practice. HF prevention trials that induct and monitor high risk
individual also require such tools for initial screening and stratification of those eligible.
Among the strengths of this study is the derivation of a risk score in a large community-
based cohort of middle aged white and black men and women, with long term follow-up and
high retention rates. There are several limitations also worth noting. Although similar to that
of the Health ABC study and other cardiovascular disease cohorts, the classification of HF
as the outcome was not validated by review of all possible events. A recent validation study
based on a large sample of hospitalizations discharged with ICD codes with high suspicion
of HF indicates that the predictive value positive (PPV) of an ICD code 428.x for HF
classified by a physician review panel was 77%, and the sensitivity was 95% 18, 28. The
corresponding PPV and sensitivity of Framingham Heart Failure criteria were 0.78 and 0.83,
respectively18, 28. Thus, the HF outcome based on hospital discharge ICD codes used in our
analyses may be considered at least as good as the Framingham HF diagnostic criteria.
However, it should be noted that our study would miss HF cases managed successfully in
outpatient settings if they were not hospitalized throughout the 15.5 year follow up period,
although this would probably apply to rather small numbers. We must also note that little
echocardiography data was available over the extended course of this cohort’s follow-up, as
a result of which we were unable to consider the potentially different predictors for systolic
vs. diastolic HF.
We conclude that the ARIC HF risk score performs well in predicting 10-year risk of
hospitalized HF in community settings. The inclusion of NT-proBNP in the ARIC HF risk
score – and even in a model restricted to age, gender and race – markedly improves the
prediction of 10-year risk of HF in middle-aged adults. These findings need replication, and
possibly calibration in other cohorts. The risk calculators presented are available on
www.ARICNEWS.net. Practice-based tools for early identification of susceptibility to HF
and its efficient monitoring in community settings may contribute to the reduction of the
growing burden of HF by enabling proactive risk management.
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Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors thank the staff and participants of the ARIC study for their important contributions.
Sources of Funding
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart,
Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C,
HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and
HHSN268201100012C). Roche Diagnostics provided reagents and the loan of an instrument to conduct the assays
of NT-proBNP.
Agarwal et al. Page 8














1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V,
Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C,
Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke
statistics--2008 update: A report from the american heart association statistics committee and stroke
statistics subcommittee. Circulation. 2008; 117:e25–e146. [PubMed: 18086926]
2. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ.
Trends in heart failure incidence and survival in a community-based population. Jama. 2004;
292:344–350. [PubMed: 15265849]
3. Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev. 2006; 11:95–107. [PubMed:
16937029]
4. Fowler PB. Evidence-based diagnosis. J Eval Clin Pract. 1997; 3:153–159. [PubMed: 9276592]
5. Mair FS, Bundred PE. The diagnosis and management of heart failure: Gp opinions. 1996; 3:121–
125.
6. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart
failure in primary care: Qualitative study. Bmj. 2003; 326:196. [PubMed: 12543836]
7. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk
profiles. Am Heart J. 2004; 148:16–26. [PubMed: 15215787]
8. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini
DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: Accf/aha guidelines
for the diagnosis and management of heart failure in adults: A report of the american college of
cardiology foundation/american heart association task force on practice guidelines: Developed in
collaboration with the international society for heart and lung transplantation. Circulation. 2009;
119:1977–2016. [PubMed: 19324967]
9. Kannel WB, D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D. Profile for
estimating risk of heart failure. Arch Intern Med. 1999; 159:1197–1204. [PubMed: 10371227]
10. Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, Bauer DC,
Satterfield S, Smith AL, Vaccarino V, Newman AB, Harris TB, Wilson PW, Kritchevsky SB.
Incident heart failure prediction in the elderly: The health abc heart failure score. Circ Heart Fail.
2008; 1:125–133. [PubMed: 19777072]
11. Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, Bauer D,
Satterfield S, Smith A, Vaccarino V. Incident heart failure prediction in the elderly: The health abc
heart failure score. 2008
12. The ARIC Investigators. The atherosclerosis risk in communities (aric) study: Design and
objectives. The aric investigators. American journal of epidemiology. 1989; 129:687–702.
[PubMed: 2646917]
13. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and
survival (from the atherosclerosis risk in communities study). Am J Cardiol. 2008; 101:1016–
1022. [PubMed: 18359324]
14. Vitelli LL, Crow RS, Shahar E, Hutchinson RG, Rautaharju PM, Folsom AR. Electrocardiographic
findings in a healthy biracial population. Atherosclerosis risk in communities (aric) study
investigators. Am J Cardiol. 1998; 81:453–459. [PubMed: 9485136]
15. Folsom AR, Lutsey PL, Astor BC, Cushman M. C-reactive protein and venous thromboembolism.
A prospective investigation in the aric cohort. Thromb Haemost. 2009; 102:615–619. [PubMed:
19806245]
16. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the dade behring n latex cystatin c assay on
the dade behring nephelometer ii system. Scand J Clin Lab Invest. 1999; 59:1–8. [PubMed:
10206092]
17. Agarwal SK, Avery CL, Ballantyne CM, Catellier D, Nambi V, Saunders J, Sharrett AR, Coresh J,
Heiss G, Hoogeveen RC. Sources of variability in measurements of cardiac troponin t in a
community-based sample: The atherosclerosis risk in communities study. Clin Chem. 2011;
57:891–897. [PubMed: 21519038]
Agarwal et al. Page 9













18. Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G,
Chambless LE. Classification of heart failure in the atherosclerosis risk in communities (aric)
study: A comparison of diagnostic criteria. Circ Heart Fail. 2012; 5:152–159. [PubMed:
22271752]
19. Gronnesby JK, Borgan O. A method for checking regression models in survival analysis based on
the risk score. Lifetime Data Anal. 1996; 2:315–328. [PubMed: 9384628]
20. Pencina MJ, D'Agostino RBS, D' Agostino RBJ, Vasan RS. Evaluating the added predictive ability
of a new marker: From area under the roc curve to reclassification and beyond. Stat Med. 2008;
27:157–172. [PubMed: 17569110]
21. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y. Integrating the
predictiveness of a marker with its performance as a classifier. Am J Epidemiol. 2008; 167:362–
368. [PubMed: 17982157]
22. Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction
models: Extension to survival analysis. Stat Med. 2011; 30:22–38. [PubMed: 20827726]
23. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal
validation of predictive models: Efficiency of some procedures for logistic regression analysis. J
Clin Epidemiol. 2001; 54:774–781. [PubMed: 11470385]
24. Braunwald, E.; Zipes, DP.; Libby, P. Heart disease : A textbook of cardiovascular medicine.
Philadelphia: Saunders; 2001.
25. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the framingham coronary
heart disease prediction scores: Results of a multiple ethnic groups investigation. Jama. 2001;
286:180–187. [PubMed: 11448281]
26. Kalogeropoulos A, Psaty BM, Vasan RS, Georgiopoulou V, Smith AL, Smith NL, Kritchevsky
SB, Wilson PW, Newman AB, Harris TB, Butler J. Validation of the health abc heart failure
model for incident heart failure risk prediction: The cardiovascular health study. Circ Heart Fail.
2010; 3:495–502. [PubMed: 20427700]
27. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz
M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. Hfsa
2010 comprehensive heart failure practice guideline. J Card Fail. 2010; 16:e1–e194. [PubMed:
20610207]
28. Rosamond WD, Chang P, Baggett C, Bertoni A, Shahar E, Deswal A, Heiss G, Chambless L.
Abstract 1454: Classification of heart failure in the atherosclerosis risk in communities (aric)
study: A comparison with other diagnostic criteria. Circulation. 2009; 120:S506.
Agarwal et al. Page 10













A Heart Failure (HF) risk score using few simple clinical variables was optimized to
predict 10 years risk of new-onset HF was developed. It is based on 15.5 years of follow-
up of the bi-racial ARIC cohort from four U.S. communities (1,487 HF events, 210,102
person-years). In African Americans and whites, a parsimonious HF risk score containing
only age, gender, race, and NT-proBNP performed comparably to the extant HF risk
scores, and also to those that incorporate a large number of risk factors. These findings
carry potential impact for the prevention and early diagnosis of HF. Awareness of a
patient’s risk of HF may lead to opportunities for patient education, proactive risk factor
management, timely use of diagnostic testing, or referral to a cardiologist, if felt
necessary by the general practitioner. Using only information readily available to
practitioners and their patients, the ARIC HF risk score improves risk stratification and
adds to the practitioner’s ability to prevent HF or to influence its natural history.
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Predicted 10-year risk of heart failure vs. percentile of risk for models parameterized as
follows: Demographic model – Age, race and sex; Demographic model + log(proBNP) –
Age, race, sex, log(NT-proBNP); ARIC basic model – age, race, sex, prevalent CHD,
diabetes, systolic blood pressure, blood pressure medication use, heart rate, smoking status,
and BMI; ARIC basic model + log(proBNP) – age, race, sex, prevalent CHD, diabetes,
systolic blood pressure, blood pressure medication use, heart rate, smoking status, BMI and
log(NT-proBNP).
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